The next board meeting for Kymera Therapeutics Inc is on 25 Jun 2025 for the purpose of Kymera Therapeutics Inc Annual General Meeting for 2025See details
Kymera Therapeutics Inc has a share price target of US$ 62, revenue growth forecast of 60.0%, and profit growth estimate of -29.7% for FY25, based on top 20 analyst calls.